Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication
Clinical trial NCT05715723 · COMPLETED
Trial details
- NCT number
- NCT05715723
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-15
- Primary completion
- 2024-11-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.